We build platforms for
AAHI adjuvant formulation profiles included in the National Institute of Health’s Vaccine Adjuvant Compendium. Adjuvant formulations are not a one-size fits all solution to enhancing immune responses. Find out which adjuvant formulation may be most suited to your purpose.
Read About Us
Working at AAHI
AAHI leverages its RNA and adjuvant formulations expertise to pioneer the development of platforms for next generation vaccines and immunotherapies.
Our in-house manufacturing, formulation, and product development services enable development of powerful prophylactic and therapeutic solutions to address real-world needs.
Our platform technology facilitates rapid vaccine and immunotherapy development and distribution, to make life-enhancing products equitably accessible around the world.
Next Generation Solutions
Our expertise in RNA vaccines and adjuvant formulations has set the stage for revolutionary development and improvement of potent, broad, and durable vaccines that are commercially scalable and accessible across diverse geographic, cultural, and economic regions.
Who Is AAHI?
AAHI is focused on solving fundamental scientific challenges that impede the ability of the biomedical community to deliver on our shared goal – protecting and improving people’s health around the world.
AAHI Is All About Collaboration
Our commitment to global equity permeates our efforts to forge collaborations and partnerships to make immunologic innovations equitably accessible to the people who most need them.